Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The diabetic heart utilizes ketone bodies as an energy source
Yuji Mizuno, Eisaku Harada, Hitoshi Nakagawa, et al.
Metabolism (2017) Vol. 77, pp. 65-72
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
Subodh Verma, John J.V. McMurray
Diabetologia (2018) Vol. 61, Iss. 10, pp. 2108-2117
Open Access | Times Cited: 790
Heart Failure in Type 2 Diabetes Mellitus
Helena Kenny, E. Dale Abel
Circulation Research (2019) Vol. 124, Iss. 1, pp. 121-141
Open Access | Times Cited: 543
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, Rodolfo San Antonio, et al.
Journal of the American College of Cardiology (2019) Vol. 73, Iss. 15, pp. 1931-1944
Open Access | Times Cited: 511
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus
Karin Rådholm, Gemma A. Figtree, Vlado Perkovic, et al.
Circulation (2018) Vol. 138, Iss. 5, pp. 458-468
Open Access | Times Cited: 436
Comprehensive quantification of fuel use by the failing and nonfailing human heart
Danielle Murashige, Cholsoon Jang, Michael D. Neinast, et al.
Science (2020) Vol. 370, Iss. 6514, pp. 364-368
Open Access | Times Cited: 400
Metabolic Coordination of Physiological and Pathological Cardiac Remodeling
Andrew Gibb, Bradford G. Hill
Circulation Research (2018) Vol. 123, Iss. 1, pp. 107-128
Open Access | Times Cited: 304
Cellular and molecular pathobiology of heart failure with preserved ejection fraction
Sumita Mishra, David A. Kass
Nature Reviews Cardiology (2021) Vol. 18, Iss. 6, pp. 400-423
Open Access | Times Cited: 288
Sodium–glucose co‐transporter 2 inhibition with empagliflozin improves cardiac function in non‐diabetic rats with left ventricular dysfunction after myocardial infarction
Salva R. Yurista, Herman H.W. Silljé, Silke U. Oberdorf‐Maass, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 7, pp. 862-873
Open Access | Times Cited: 276
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
Anastasios Tentolouris, Panayotis K. Vlachakis, Evangelia Tzeravini, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 16, pp. 2965-2965
Open Access | Times Cited: 243
Ketone bodies: from enemy to friend and guardian angel
Hubert Kolb, Kerstin Kempf, Martin Röhling, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 229
Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease
Salva R. Yurista, Cher‐Rin Chong, Juan J. Badimón, et al.
Journal of the American College of Cardiology (2021) Vol. 77, Iss. 13, pp. 1660-1669
Open Access | Times Cited: 162
Short-chain fatty acid, acylation and cardiovascular diseases
Xiaofeng Chen, Xiangqi Chen, Xiaoqiang Tang
Clinical Science (2020) Vol. 134, Iss. 6, pp. 657-676
Closed Access | Times Cited: 149
3-Hydroxybutyrate as a Metabolite and a Signal Molecule Regulating Processes of Living Organisms
Justyna Mierziak, Marta Burgberger, Wioleta Wojtasik
Biomolecules (2021) Vol. 11, Iss. 3, pp. 402-402
Open Access | Times Cited: 126
Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges
Julia Ritterhoff, Rong Tian
Nature Reviews Cardiology (2023) Vol. 20, Iss. 12, pp. 812-829
Closed Access | Times Cited: 90
Ketones and the Heart: Metabolic Principles and Therapeutic Implications
Timothy Matsuura, Patrycja Puchalska, Peter A. Crawford, et al.
Circulation Research (2023) Vol. 132, Iss. 7, pp. 882-898
Open Access | Times Cited: 72
Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
Keming Huang, Xianling Luo, Bin Liao, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 45
Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction
Qiuyu Sun, Berna Güven, Cory S. Wagg, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 4, pp. 360-371
Closed Access | Times Cited: 31
Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling
Gábor Vörös, Joris Ector, Christophe Garweg, et al.
Circulation Heart Failure (2018) Vol. 11, Iss. 12
Open Access | Times Cited: 123
Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats
H Oshima, Takayuki Miki, Atsushi Kuno, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 368, Iss. 3, pp. 524-534
Open Access | Times Cited: 110
Cardiac ketone body metabolism
Azrul Abdul Kadir, Kieran Clarke, Rhys Evans
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 6, pp. 165739-165739
Closed Access | Times Cited: 91
Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
Lin Wang, Yin Cai, Liguo Jian, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 84
Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults
Adrián Soto-Mota, Hannah Vansant, Rhys Evans, et al.
Regulatory Toxicology and Pharmacology (2019) Vol. 109, pp. 104506-104506
Open Access | Times Cited: 80
Myocardial ketone body utilization in patients with heart failure: The impact of oral ketone ester
Luca Monzo, Kamil Sedláček, Katarína Hromaníková, et al.
Metabolism (2020) Vol. 115, pp. 154452-154452
Closed Access | Times Cited: 76
Pathophysiology and risk factors of peripartum cardiomyopathy
Martijn F. Hoes, Zoltàn Arany, Johann Bauersachs, et al.
Nature Reviews Cardiology (2022) Vol. 19, Iss. 8, pp. 555-565
Open Access | Times Cited: 49
Function and mechanism of histone β-hydroxybutyrylation in health and disease
Tingting Zhou, Xi Cheng, Yanqiu He, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top